from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0270/fadD2

LFCtreatmentdescriptionclass of inhibitor

-0.478

Amikacinug/mL Amikacintranslation

-1.434

Cap5-10ug/mL Capreomycintranslation

-1.886

Rox10-50 ug/mL Roxithromycintranslation

-1.135

SM2-5 ug/mL Streptomycintranslation

-0.317

Tet5-10 ug/mL Tetracyclinetranslation

0.049

Rif0.2-5ug/mL Rifampicintranscription

-0.993

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.734

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.650

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.803

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.501

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.086

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.970

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.034

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.012

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.019

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.525

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.441

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.283

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.365

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.066

KCN5-20 ug/mL Potassium cyaniderespiration

-0.476

NaN30.2-2 mM Sodium aziderespiration

-0.454

Nigericin50 uM Nigericinrespiration

0.848

TRC10-150 ug/mL Triclosanrespiration

0.695

TRZ10-25 ug/mL Thioridazinerespiration

-0.816

Valinomycin0.5-10 uM Valinomycinrespiration

-1.417

ZnSO42 mM ZnSO4respiration

0.904

menadione6-10 ug/mL Menadionerespiration

-0.001

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.554

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.076

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.412

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.217

NRP_1Non-replicating persistence stage 1dosRassociated

-0.547

Amp0.2mg/mL AmpicillincellWall

-0.165

Cephalexin20-100 ug/mL CephalexincellWall

-0.754

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.535

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.274

EMB10-20 ug/mL EthambutolcellWall

-0.869

Eta12-40 ug/mL EthionamidecellWall

-0.296

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.837

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.255

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.169

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.599

BZA0.12 mg/mL BenzamidearomaticAmides

0.149

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.097

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.671

H2O24 mM hydrogen peroxideDNAdamaging

0.115

Levo10 ug/mL LevofloxacinDNAdamaging

-0.040

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.936

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.111

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.116

UVUV-irradiationDNAdamaging

-0.460

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.353

Antimycin12.5-50 ug/mL Antimycin A?

-0.691

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.222

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.506

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.944

PA8240.2-2 ug/mL PA-824?

-0.042

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.138

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.139

Verapamil50 uM Verapamil?

-0.554

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.652

methoxatin10-20 ug/mL Methoxatin?